Medical Equipment

Minimally Invasive Urinary Incontinence Device Market Growth Opportunities: Insights from 2025–2029

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Minimally Invasive Urinary Incontinence Device Market Expected To Expand Between 2025 And 2029?

The minimally invasive urinary incontinence device market size has witnessed strong expansion over recent years. This market is anticipated to rise from $1.15 billion in 2024 to $1.25 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.2%. The historical surge can be attributed to increased awareness concerning urinary incontinence treatment options, greater availability of minimally invasive procedures, an escalating number of aging individuals requiring bladder control solutions, the introduction of novel sling and bulking agent systems, and enhancements in surgical training for incontinence management.

The minimally invasive urinary incontinence device market is projected for robust expansion in the coming years, with its size expected to reach $1.76 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.9%. This anticipated growth throughout the forecast period stems from several factors, including broader reimbursement coverage for minimally invasive urinary therapies, a heightened preference for outpatient and same-day medical interventions, an increasing emphasis on patient comfort alongside faster recuperation, greater acceptance in developing nations, and the rising prevalence of incontinence linked to lifestyle choices and various medical conditions. Key trends expected during this period involve ongoing advancements in device miniaturization and material safety, the incorporation of wireless monitoring and control capabilities, intensive research and development into nerve stimulation technologies, progress in adjustable and reusable sling systems, and the utilization of 3D printing to create personalized urinary devices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27350&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Minimally Invasive Urinary Incontinence Device Industry?

The escalating occurrence of prostate cancer is projected to propel the expansion of the minimally invasive urinary incontinence device market. Prostate cancer is characterized by the unchecked growth of cells within the prostate gland, potentially impacting urinary and reproductive health. The increasing number of prostate cancer diagnoses is predominantly driven by an aging male demographic, given that older age represents a significant risk factor for the illness. Minimally invasive urinary incontinence devices are designed to aid in managing urinary complications associated with prostate cancer by delivering targeted support to control bladder leakage, reinstate normal urinary function, and considerably enhance the overall quality of life for patients undergoing treatment or recovery. For instance, in June 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, an estimated 255,395 new cases of prostate cancer were diagnosed in the United States in 2022, and in 2023, the disease caused the deaths of approximately 33,881 men. Consequently, the rising incidence of prostate cancer is fueling the growth of the minimally invasive urinary incontinence device market.

What Are The Major Segment Categories Driving The Minimally Invasive Urinary Incontinence Device Market Growth?

The minimally invasive urinary incontinence device market covered in this report is segmented

1) By Type: Tension Free Vaginal Tape (TVT), Tension Free Vaginal Tape (TVT) Obturator System, Other Types

2) By Age Group: Adults (18-65 years), Senior Population (65 Years And Above), Pediatric Population

3) By End-User: Hospitals, Clinics, Home Healthcare Settings, Research Institutions

Subsegments:

1) By Tension Free Vaginal Tape (TVT): Mid Urethral Sling, Retropubic Sling, Single Incision Sling

2) By Tension Free Vaginal Tape Obturator System (TVTO): Inside Out Approach, Outside In Approach

3) By Other Types: Bulking Agents, Artificial Urinary Sphincter, Sling Systems

What Are The Major Trends Driving The Growth Of The Minimally Invasive Urinary Incontinence Device Market?

Leading companies within the minimally invasive urinary incontinence device market are prioritizing the creation of advanced products, such as neuromodulation therapy devices, to deliver effective long-term solutions with minimal surgical intervention. These neuromodulation therapy devices are implants that work by activating bladder-controlling nerves to regulate urinary function, thereby assisting in incontinence management by improving bladder control and reducing accidental leakage. For example, in December 2023, BlueWind Medical Ltd., a US-based company specializing in neurostimulation devices, unveiled its Revi implantable tibial neuromodulation (iTNM) device. This particular device is a battery-free, minimally invasive implant engineered to address urge urinary incontinence (UUI) through stimulation of the posterior tibial nerve. The device is inserted near the ankle in a single outpatient procedure under local anesthesia and is activated using a lightweight wearable, facilitating convenient symptom management for patients at home. This introduction underscores the ongoing trend of bringing innovative, patient-friendly neuromodulation solutions to the urinary incontinence device market.

Who Are The Core Companies Influencing The Minimally Invasive Urinary Incontinence Device Market Landscape?

Major companies operating in the minimally invasive urinary incontinence device market are Johnson & Johnson Services Inc., Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Coloplast A/S, Teleflex Incorporated, Hollister Incorporated, CooperSurgical Inc., B. Braun Melsungen Aktiengesellschaft, LiNA Medical ApS, BlueWind Medical Ltd., Caldera Medical Inc., Neuspera Medical Inc., InControl Medical LLC, UroMems Inc., Rigicon Inc., Valencia Technologies Corporation, Zephyr Surgical Implants SA.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-urinary-incontinence-device-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Minimally Invasive Urinary Incontinence Device Market?

North America was the largest region in the minimally invasive urinary incontinence device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive urinary incontinence device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Minimally Invasive Urinary Incontinence Device Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27350&type=smp

Browse Through More Reports Similar to the Global Minimally Invasive Urinary Incontinence Device Market 2025, By The Business Research Company

Ai Powered Personal Finance Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ai-powered-personal-finance-management-global-market-report

Personal Finance Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/personal-finance-software-global-market-report

Personal Finance Apps Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/personal-finance-apps-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795